Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 29;15(1):e0228115.
doi: 10.1371/journal.pone.0228115. eCollection 2020.

Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes

Affiliations
Free PMC article

Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes

Huguet V Landa-Galvan et al. PLoS One. .
Free PMC article

Abstract

Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors, with insulin resistance as a critical component for its development. Insulin signaling in the heart leads to Akt (also known as PKB) activation, a serine/threonine protein kinase, which regulates cardiac glucose metabolism and growth. Cardiac metabolic inflexibility, characterized by impaired insulin-induced glucose uptake and oxidation, has been reported as an early and consistent change in the heart of different models of MetS and diabetes; however, the evaluation of Akt activation has yielded variable results. Here we report in cardiomyocytes of MetS rats, diminished insulin-induced glucose uptake and Akt activation, evaluated by its impaired mobilization towards the plasma membrane and phosphorylation, and reflected in a re-distribution of its interacting proteins, assessed by label-free mass spectrometry (data are available via ProteomeXchange with identifier PXD013260). We report 45 proteins with diminished abundance in Akt complex of MetS cardiomyocytes, mainly represented by energy metabolism-related proteins, and also, 31 Akt-interacting proteins with increased abundance, which were mainly related to contraction, endoplasmic reticulum stress, and Akt negative regulation. These results emphasize the relevance of Akt in the regulation of energy metabolism in the heart and highlight Akt-interacting proteins that could be involved in the detrimental effects of MetS in the heart.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Glucose tolerance test.
A) Glucose determinations performed in control and MetS rats at 15, 30, 60 and 120 minutes after intraperitoneal injection of glucose (2g / kg). N = 6, for both groups. **P < 0.01, ***P < 0.001 vs basal (0 min). &&P <0.01, &&&P < 0.001 vs control rats. B) Area under the curve of the glucose tolerance test. ***P < 0.001 vs control rats.
Fig 2
Fig 2. 3H-2-deoxy-D-glucose uptake.
Cardiomyocytes of A) Control and B) MetS rats were stimulated with 100 nM insulin for 30 min, and the 3H-2-deoxy-D-glucose uptake was measured in a scintillation counter. N = 5, for both groups. *P < 0.05.
Fig 3
Fig 3. Akt mobilization towards caveolin-3 regions in response to insulin.
A) Control and B) MetS cardiomyocytes were stimulated with 100 nM insulin for 2 min, and the Akt (green) and caveolin-3 (red) localization was evaluated by immunostaining using confocal microscopy. C) Akt/caveolin-3 weighted colocalization coefficient. Scale bar = 20 μm. N = 3 rats, n = 30 cardiomyocytes, for both groups. ***P < 0.001.
Fig 4
Fig 4. Akt phosphorylation in response to insulin.
Control and MetS cardiomyocytes were stimulated with the indicated insulin concentrations for 10 min, and Akt phosphorylation in its main activation residues was evaluated by Western blot. A) pAkt Ser473. Data were normalized with the maximum value being 1 for both curves (N = 5 control, 3 MetS. *P < 0.05, ***P < 0.001 vs basal in control cardiomyocytes. #P < 0.05, ##P < 0.01 vs basal in MetS cardiomyocytes); B) pAkt Thr308 (N = 3, for both groups. **P < 0.01 vs basal. &&P < 0.01 vs control rat cardiomyocytes).
Fig 5
Fig 5. Proteins differentially interacting with Akt in MetS cardiomyocytes.
Control and MetS cardiomyocytes were stimulated with 100 nM insulin for 10 min; Akt CoIP was performed, and the relative abundance of proteins interacting with Akt was assessed by label-free mass spectrometry. A) Volcano plot representing all filtered proteins: gray circles correspond to the proteins that are in complex with Akt but did not change their abundance between the MetS and control samples (69), red circles correspond to the proteins with increased abundance in Akt complex in MetS (29), green circles correspond to the proteins with diminished abundance in Akt complex in MetS (44). The X-axis corresponds to the P-value of each detected protein in the technical triplicate (values represented as -Log10), and Y-axis corresponds to the ratio of the average Hi3 intensities (MetS/C) of the technical triplicate for each detected protein (values are represented as Log2). Proteins were classified according to the biological process related to their function using STRING based on the GO database, and pie charts depicting this functional classification were constructed for B) proteins with diminished interaction with Akt in MetS and C) proteins with increased interaction with Akt in MetS.
Fig 6
Fig 6. Validation of a subset of Akt-interacting proteins.
Akt interaction with A) GAPDH, B) 14-3-3 ζ, and C) Hsp60 was evaluated in insulin-stimulated control and MetS cardiomyocytes (100 nM insulin for 10 min) by Akt immunoprecipitation and Western Blot. Representative image of three independent experiments. IgG heavy chain (HC) is presented as loading control. *P < 0.05, **P < 0.01 vs control. Expression levels of D) GAPDH, E) 14-3-3 ζ, and F) Hsp60 were evaluated in cardiomyocytes lysates by Western Blot. Representative image of four independent experiments. **P < 0.01 vs control.

Similar articles

Cited by

References

    1. Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018;42 Suppl 1:S10–S5. Epub 2018/04/14. 10.1016/j.jcjd.2017.10.003 . - DOI - PubMed
    1. Grundy SM, Hansen B, Smith SC Jr., Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol. 2004;24(2):e19–24. Epub 2004/02/10. 10.1161/01.ATV.0000112379.88385.67 . - DOI - PubMed
    1. Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–8. Epub 2017/08/05. 10.1007/s00125-017-4390-4 - DOI - PMC - PubMed
    1. Mahmoud AM. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms. Adv Exp Med Biol. 2017;999:207–30. Epub 2017/10/13. 10.1007/978-981-10-4307-9_12 . - DOI - PubMed
    1. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006;291(4):H1489–506. Epub 2006/06/06. 10.1152/ajpheart.00278.2006 . - DOI - PubMed

Publication types

Grants and funding

This work was supported by Cinvestav-IPN and partially by CONACYT/SEP Research Grant 167673 (to J.A.O-R.); CONACYT/SEP Research Grant A1-S-9082 (to A.R.); PRODEP-SEP grant to the Academic Group Cinvestav-CA-10, ID 28915/2018 (to A.R. and J.A.O-R.); SEP-CINVESTAV 2018 grant #2 (to A.R.); Estimulo a la Investigacion Medica “Miguel Aleman Valdes” 2018 (to J.A.O-R.) and by a CONACYT scholarship grant, No. 278067 (to H.V.L-G.) and No. 295776 (to T.R-G.).